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  Primary testicular tumors are the most common causes 
of  cancer  in  male  dogs.  Overall,  the  majority  of  canine 
patients should be cured by testicular surgery. However, 
tumor  markers  are  not  well-known  in  veterinary 
medicine.  We  sought  to  determine  using  immunohisto-
chemistry whether the combined human testicular tumor 
markers (placental alkaline phosphatase, OCT3/4, CD30, 
alpha-fetoprotein,  inhibin-alpha,  vimentin,  c-KIT,  and 
desmin)  are  expressed  in  canine  seminomas  and  Sertoli 
cell  tumors  (SCTs).  We  examined  35  canine  testicular 
tumors, 20 seminomas and 15 SCTs. c-KIT was expressed 
markedly  in  canine  seminomas.  Both  inhibin-alpha  and 
vimentin were expressed significantly in canine SCTs. The 
results  of  this  study  demonstrate  differences  and 
similarities between tumor marker expression of testicular 
t u m o r s  i n  d o g s  a n d  h u m a n s .  A l l  t h e  m a i n  m a r k e r s  i n  
current  routine  use  are  discussed  as  well  as  potential 
u s e f u l  m a r k e r s  f o r  b e n i g n  and  malignant  tumors,  and 
tumor progression.
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Introduction 
Testicular tumors arise from germ cells and sex-cord 
stromal elements of the testis [22], and are divided into four 
general categories: germ cell tumors including seminoma, 
teratoma, embryonal carcinoma, and yolk sac carcinoma 
arising from the germinal epithelium of the seminiferous 
tubules; sex-cord stromal tumors, including Sertoli cell 
tumor (SCT) and Leydig (interstitial) cell tumor; mixed 
germ cell sex-cord stromal tumors; and primary tumors not 
specific to the testis [22,30,32]. The major tumors are 
seminoma and SCT, which occur with equal frequency, 
showing a prevalence of 0.068-4.6% in mature and old 
male dogs [30,31,34]. Seminoma is derived from the germ 
cells that constitute the spermatogenic epithelium within 
the seminiferous tubules. SCT arises from the supporting 
cells within the seminiferous tubules. It is most common in 
dogs, but has also been reported in stallions, rams, bulls, 
goats, and cats [21,23]. 
In humans, testicular tumors are the most common 
cancers found in men between 15-35-years-of-age, where 
90% are germ cell tumors [14,26,32]. Since the rate of 
testicular neoplasms is increasing, much research has been 
carried out to more accurately diagnose and manage these 
patients [2,11]. In particular, many immunohistochemical 
markers have been introduced to accurately establish 
histological diagnoses and to investigate tumor pathogene-
sis [3,18]. Markers including cytokeratins, c-KIT, CD30, 
epithelial membrane antigen, inhibin-alpha, OCT3/4, 
placental alkaline phosphatase (PLAP) and alpha 
fetoprotein (AFP) are sensitive and specific for the 
diagnosis of human testicular tumors [13,17,27,35]. 
Although tumor markers in canine testicular tumors have 
been studied, relatively less is known, which presently 
limits their use in diagnosis and evaluation of tumor 
pathogenesis.
In the present study, we examined tumor markers 
including PLAP, AFP, inhibin-alpha, vimentin, OCT3/4, 
CD30, desmin, and c-KIT to determine expression of these 
proteins and an appropriate antibody panel. To accomplish 
this, we employed immunohistochemical staining of 
canine seminomas and SCTs.2    Chi-Ho Yu et al.
Table 1. Primary antibodies used for immunohistochemical 
staining
Antibody Clone Type Dilution
PLAP PL8/F6 Monoclonal Ready to use
AFP C3 Monoclonal 1：400
Inhibin-α R1 Monoclonal 1：100
Vimentin Vim3B4 Monoclonal 1：400
OCT 3/4 C-10 Monoclonal 1：50
c-KIT C-19 Monoclonal 1：50
Desmin 33 Monoclonal 1：100
CD30 Ber-H2 Polyclonal 1：400
PLAP: placental alkaline phosphatase, AFP: alpha fetoprotein.
Table 2. Frequency of expression of the antigen in canine 
seminomas (n = 20) and Sertoli cell tumors (n = 15)*
Antibody
No. immunopositive cases (%)
Seminoma Sertoli cell tumor
PLAP   4 (20%)   6 (40%)
AFP   8 (40%)   8 (53.3%)
Inhibin-α   9 (45%) 14 (93.3%)
Vimentin   5 (25%) 14 (93.3%)
OCT 3/4   0 (0%)   0 (0%)
c-KIT 20 (100%) 10 (66.6%)
Desmin   6 (30%)   5 (33.3%)
CD30   0 (0%)   0 (0%)
*The result was scored as positive if ＞ 10% of tumor cells showed 
the staining. PLAP: placental alkaline phosphatase, AFP: alpha 
fetoprotein.
Materials and Methods
Tissues from testicular tumors in dogs
Testicular specimens from 35 male dogs with seminomas 
(n = 20) or SCTs (n = 15) were obtained from the files of the 
Department of Pathobiology, Small Animal Tumor 
Diagnostic Center, Konkuk University, Seoul, Korea. In 
addition, two normal testicular samples from neutered 
male dogs were used as negative controls. Histopatholo-
gical analyses based on hematoxylin and eosin staining 
were performed. 
Immunohistochemical staining
Each testis was fixed in 10% neutral buffered formalin. 
Blocks that contained testis tumor tissue were embedded in 
paraffin wax. Serial 4 μm-thick sections were acquired 
from each paraffin-block for immunohistochemical 
staining. Monoclonal and polyclonal antibodies (Table 1) 
included PLAP (Biogenex, USA), AFP (Biogenex), 
inhibin-alpha (Dako, USA), vimentin (Dako), OCT3/4 
(Santa Cruz Biotechnology, USA), CD30 (Santa Cruz 
Biotechnology), desmin (Biogenex, USA), and c-KIT 
(Dako, USA). Sections were deparaffinized in xylene, 
rehydrated in a graded ethanol series, treated with 3% 
hydrogen peroxide solution for 20 min at room 
temperature, and washed three times with phosphate- 
buffered saline (PBS; pH 7.4, 137 mM NaCl, 2.7 mM KCl, 
10 mM Na2HPO4, 2 mM KH2PO4). For inhibin-alpha, 
OCT3/4 and CD30, antigen retrieval was performed by 
heating slides in Tris-EDTA buffer (pH 9) in a microwave 
oven (650 W, high power) for 20 min. After 3 min washes 
with PBS, sections to be stained with AFP, vimentin, and 
c-KIT antibodies were incubated in a blocking solution of 
5% normal goat serum (Vector Laboratories, USA) for 30 
min. All primary antibodies were incubated with sections 
overnight at 4
oC. To “visualize” immunolabeling, a 
two-step EnVision system (Dako, USA) was applied after 
removal of the primary antibody. In this system, EnVision 
rabbit/mouse reagent conjugated to horseradish 
peroxidase was applied for 40 min at room temperature. 
The slides were subsequently washed four times in PBS 
and incubated with the supplied substrates until the desired 
color intensity developed. The reaction was stopped by 
washing in distilled water. Sections were counterstained 
with Harris hematoxylin.
Digital  image  preparation  and  assessment  of 
immunohistochemical labeling
Images were acquired using an Olympus BX41 
microscope (Olympus, USA) fitted with a Leica DFC 290 
digital camera (Leica, Switzerland) and analyzed for 
positive signals using Image-Pro Plus software ver. 4.1 
(Media Cybernetics, USA). The immunolabeling was 
scored as positive if ＞ 10% of tumor cells displayed 
staining. 
Results
Characteristics  of  histopathology  and  immuno-
staining in seminoma and SCTs
The results of immunohistochemical studies are 
summarized in Tables 2 and 3. PLAP, AFP, inhibin-alpha, 
vimentin, desmin, and c-KIT were expressed in 
seminomas and SCTs, while OCT3/4 and CD30 were not 
expressed. In normal Leydig cells, inhibin alpha, vimentin, 
and desmin antibodies were weakly immunoreactive. 
Normal Sertoli cells had focal staining for vimentin and 
c-KIT. PLAP, AFP, OCT3/4, and CD30 produced no 
immunoreactivity in normal testis (data not shown).
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Table 3. Immunoreactivity of PLAP, AFP, inhibin-alpha, vimentin, 
OCT3/4, CD30, desmin, and c-KIT in normal canine testis (n = 2)*
Antibody
Normal testis
Leydig Sertoli Spermatogenic 
cell cell cell
PLAP 򰠏򰠏 򰠏
AFP 򰠏򰠏 򰠏
Inhibin-α 1+ 1+ 򰠏
Vimentin 2+ 2+ 򰠏
OCT 3/4 򰠏򰠏 򰠏
c-KIT 򰠏 1+ 򰠏
Desmin 1+ 򰠏򰠏
CD30 򰠏򰠏 򰠏
*򰠏 =  no staining, 1+ = ＜10% positive cells, 2+ = 10 to 50% positive
cells, 3+ = ＞50% positive cells. PLAP; placental alkaline 
phosphatase, AFP; alpha fetoprotein.
Fig. 1. Immunohistochemical markers in canine seminoma. (A) Seminomas consisted of aggregates of germ cells that filled the affected
seminiferous tubules. The tumor cells were large and polyhedral with vesicular nuclei and prominent nucleoli. H&E stain. (B-F) 
Positive signals to tumor cells; (B) alpha-fetoprotein, (C) inhibin-alpha, (D) vimentin, (E) desmin and (F) c-KIT. Immunostain and 
counterstain with Harris hematoxylin. Scale bars = A: 350 μm, B-F: 140 μm.
filled the lumens or sheets of the affected seminiferous 
tubules. These cells replaced the normal lining of 
spermatogenic and Sertoli cells. Large and irregular cellular 
aggregates and small clusters of cells were seen to varying 
extents. Dense fibrous bands subdivided the tumor into 
large discrete nodules. The tumor cells were large and 
polyhedral with vesicular nuclei and prominent nucleoli 
(Fig. 1A). PLAP staining was moderate-to-diffuse in four 
cases. AFP and inhibin-alpha were positive in eight and nine 
cases, respectively. AFP was diffusely expressed in tumor 
cells (Fig. 1B), while inhibin-alpha demonstrated diffuse 
immunoreactivity (Fig. 1C). Vimentin and desmin were 
positive in five and six separate cases, respectively. 
Expression of vimentin produced strongly positive 
immunoreactivity in some tumor cells within some 
seminomas (Fig. 1D). Expression of desmin was diffuse and 
focal to the cytoplasm of tumor cells (Fig. 1E). No OCT3/4 
or CD30 staining was evident in the tumors (data not 
shown). C-KIT was strongly positive in all cases (Fig. 1F).
In SCTs, there was abundant fibrous tissue stroma. Cells 
within the tumor resembled Sertoli cells that normally 
populate the seminiferous tubules, and were arranged into 
sheets or tubules separated by fibrous connective tissue. 
The tumor cells had small, round or elongated nuclei with 
an eosinophilic cytoplasm (Fig. 2A). Of 15 SCT samples, 
six cases were positive for PLAP with weak and focal 
immunostaining. In eight cases, AFP was expressed in the 
cytoplasm of tumor cells (Fig. 2B). Fourteen cases were 
positive for inhibin-alpha and vimentin. While the tumor 
cells were strongly positive for inhibin-alpha (Fig. 2C), 
they were only weakly positive for vimentin (Fig. 2D). All 
SCTs were negative for OCT3/4 (data not shown). CD30 
was not expressed in tumor cells (data not shown). Focal 
immunostaining of desmin was observed in five cases (Fig. 
2E). Ten cases were positive for c-KIT, where its 
expression was distributed diffusely but strongly in the 
cytoplasm of tumor cells (Fig. 2F). 
Discussion
Primary testicular tumors are common in mature and old 
male dogs [34]. The main types of testicular tumors in dogs 
are seminomas and SCTs, which are associated with 4    Chi-Ho Yu et al.
Fig. 2. Immunohistochemical markers in canine Sertoli cell tumors. (A) Cells within the tumor resemble Sertoli cells that normally 
populate the seminiferous tubules and are arranged into sheets or tubules separated by fibrous connective tissues. H&E stain. (B-F) 
Positive signals to tumor cells; (B) alpha-fetoprotein, (C) inhibin-alpha, (D) vimentin, (E) desmin and (F) c-KIT. Immunostain and 
counterstain with Harris hematoxylin. Scale bars = A: 350 μm, B-F: 140 μm.
chryptorchidism. In humans, testicular tumors are the most 
common cancers found in men, with an increasing rate of 
incidence [26,32]. Substantial research on human 
testicular tumors has resulted in more accurate diagnoses 
and better management of patients [3,11]. In particular, 
many tumor markers have been found for tumor 
pathogenesis [1,4,6]. Of these markers, cytokeratins, 
c-KIT, CD30, epithelial membrane antigen, inhibin-alpha, 
OCT3/4, PLAP, and AFP are widely used because of their 
sensitivity and specificity. The usefulness of these as tumor 
markers has been assessed in many studies [13,17,27,35]. 
Canine testicular tumor markers have been studied 
[23,28,34]. However, such veterinary tumor markers in 
male canine patients still require more study to be useful in 
accurate diagnosis. Thus, the purpose of our present study 
was to establish the specificity of tumor markers including 
PLAP, AFP, inhibin-alpha, vimentin, OCT3/4, CD30, 
desmin, and c-KIT in canine seminoma and SCT.
In the current seminoma series, c-KIT was found to be the 
most sensitive marker, because tumor cells of all 
seminoma cases were homogeneously and strongly 
positive for the antibody. c-KIT is a product of the c-KIT 
oncogene, which encodes a type III transmembrane 
tyrosine kinase receptor that is required in normal 
spermatogenesis. High expression of c-KIT is found in 
human testicular germ cell tumors, especially in human 
seminoma [26]. KIT signal transduction appears to be an 
important pathway for carcinogenesis of seminoma [12]. 
Our result demonstrates that c-KIT is potently expressed 
and is potentially a specific tumor marker in canine 
seminoma, similar to human tumors. OCT3/4, also known 
as otf3 or pou5f1, is a member of the POU family of 
transcription factors expressed in pluripotent mouse and 
human embryonic stem and germ cells [7,10,29]. 
Unexpectedly, OCT3/4, which is regarded as a highly 
sensitive marker for human seminoma and embryonal 
carcinoma [2,33], was not expressed in any canine 
seminoma. OCT3/4 may not be a reliably specific tumor 
marker in canine seminoma. PLAP, a membrane-bound 
enzyme normally synthesized by placental syncytiotro-
phoblasts [4], has been widely applied in the significant 
markers of human seminoma. In contrast, PLAP staining 
was detected weakly and heterogeneously in canine SCTs. 
Although a positive reaction was observed in 20% of cases, 
the result was less significant than that observed in human 
seminoma PLAP immunostaining. This result might be 
related with the classification of testicular tumors 
including two types of seminoma. The first type is classical 
seminoma (SE) and the second type is spermatocytic 
seminoma (SS). Grieco et al. [8] showed that neoplastic 
cells are immunoreactive for PLAP in all cases with SE. 
Neoplastic cells in SS are essentially negative for PLAP 
[8]. Therefore, our result combined with the observations 
of Grieco et al. [8] indicate that 20% cases displaying a 
positive reaction were likely SE and the 80% cases 
displaying negative reaction were SS. Inhibin-alpha, a 
subunit of inhibin, is secreted mainly from testicular 
Sertoli cells with an additional small contribution from 
Leydig cells [4,34]. Although little is known about the cells 
secreting inhibin in primary testicular tumors of humans 
and older animals [5,9,16], inhibin immunoreactivity has 
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testicular tumors. In the current seminoma series, 
inhibin-alpha was observed in the cytoplasm of tumors cell 
in 45% of the cases. Vimentin and desmin was expressed in 
25% and 30%, respectively, of canine seminoma samples. 
As for vimentin and desmin, unlike the diffuse cytoplasmic 
staining present in SCTs, immunoreactivity in seminomas 
was observed confined to the cytoplasm of the tumor cells. 
Vimentin and desmin are known as markers of 
mesenchymal origin tumors including connective tissue, 
endothelium, hematopoietic cell, and muscle. Because of 
the origin of seminoma is germ cells originating from 
epithelial tissue, vimentin and desmin are not appropriate 
markers. CD30 is a membrane glycoprotein of the tumor 
necrosis factor receptor superfamily, which plays a useful 
role in identifying primary embryonal carcinoma in 
humans [33]. CD30 is also useful for distinguishing 
embryonal carcinoma from seminoma [19]. When the 
fixation is not adequate, seminoma may be confused with 
the solid pattern of embryonal carcinoma [36]. The 
distinction between seminoma and embryonal carcinoma 
is very important because the treatment differs. Our result 
shows that CD30 was not expressed in canine seminoma. 
Although there was no case of embryonal carcinoma in this 
study, this result suggests that CD30 can be used to 
differentiate embryonal carcinoma from seminoma. 
These immunohistochemical results demonstrate that 
c-KIT is a sensitive marker for seminoma in dogs. In 
human seminoma, c-KIT is expressed in seminomas at the 
high prevalence rate of 88-100%, making it one of the most 
effective immunohistochemical markers [1,18,26]. 
Although PLAP, AFP, inhibin-alpha, desmin, and vimentin 
immunoreactivity were observed in this study, they did not 
demonstrate significant results. 
The immunoreactivity of SCTs indicates that inhibin- 
alpha and vimentin were the most remarkable immuno-
reactivity of all the antibodies used in this study. Inhibin- 
alpha and vimentin were expressed with a high prevalence 
rate of 93.3% and were diffusely and moderately evident in 
the cytoplasm of neoplastic cells. Previous studies did not 
detect immunohistochemical expression of inhibin-alpha 
in SCTs in dogs [31,34]. In this study, however, this 
expression was observed in 93.3% of SCTs. Grootenhuis et 
al. [9] showed that peripheral levels of immunodetectable 
inhibin in dogs with SCTs are higher than those in normal 
dogs. Kawakami et al. [15] also demonstrated that blood 
plasma inhibin alpha concentration of dogs with SCT is 
higher than normal testis. In human testicular SCT, 
Iczkowski  et al. [11] reported positive inhibin-alpha 
immunostaining in 10 of 11 (91%) testicular SCT. The 
results of our study combined with those of Grootenhuis et 
al. [9], Kawakami et al. [15] and Iczkowski et al. [11] show 
that inhibin-alpha is likely to be the material secreted from 
the neoplastic cells of SCTs. In the current series, inhibin 
alpha immunostaining of Sertoli cells was evident in 
normal testis. The staining intensity in normal Sertoli cells 
was consistently lower than in the tumor cells of SCTs. 
Sertoli cells are the main source of inhibin production in 
the male. This result also suggests that neoplastic Sertoli 
cells in SCTs produce abundant inhibin alpha. Vimentin is 
a major intermediate filament present in the cytoplasm of 
Sertoli cells, and it has been used to identify these cells 
[24]. In humans, vimentin immunostaining is positive in 
SCTs [20]. Similar to human studies, our canine study 
showed that vimentin might be still the intermediate 
filament forming the basic structure of the cells of canine 
SCTs. PLAP was positive in some cases, although, in 
theory, they should not be expressed in SCTs. In humans 
PLAP immunostaining is also negative in SCTs [16,20]. To 
more precisely determine the expression profile of these 
proteins in canine SCTs, further longitudinal studies 
should be performed. CD30 was not found in SCTs, which 
is consistent with the idea that CD30 is expressed only in 
embryonal carcinoma. OCT3/4 was not identified in SCTs. 
SCT and seminoma reportedly became OCT3/4-positive 
in humans, but such an immunoreaction in neoplastic cells 
was not presently demonstrated. Desmin was expressed 
focally, and only five cases were positive for the cytoplasm 
of tumor cells. Although c-KIT and AFP were expressed 
with a diffuse pattern in 10 cases of SCT, they were a 
limited marker compared with inhibin-alpha or vimentin. 
Based on these results, c-KIT is the most sensitive marker 
in canine seminomas, while inhibin-alpha and vimentin are 
the most sensitive markers in canine SCTs. Although 
OCT3/4 and PLAP are regarded as the most suitable 
immunohistochemical markers in human germ cell tumors 
including seminoma, these were either not expressed or 
only weakly expressed in thecanine seminomas presently 
examined. One interpretation of these results might be that 
all the antibodies used in this experiment were produced 
against human proteins. As a result, these antibodies might 
fail to detect canine PLAP or OCT3/4. However, it is also 
reasonable to think that OCT3/4 and PLAP are not 
effective markers for canine seminoma. Inhibin-alpha and 
vimentin were expressed markedly in canine SCTs in a 
similar fashion as in human cells. Therefore, these proteins 
are specific markers in canine SCTs. 
In conclusion, the results of this study demonstrate that 
there are differences and similarities between the 
expression of testicular tumor markers in dogs and 
humans. Further investigation is required to determine 
whether expression of c-KIT, inhibin alpha, vimentin, 
AFP, and PLAP is related with tumor metastasis or 
malignancy, and to elucidate the role of these proteins in 
the development of canine testicular tumors.
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